Furthermore, in HCC, MEG3 could inhibit metastasis by sponging miR-544b and miR-5195-3p, thereby upregulating target genes B-cell translocation gene (BTG2) and FOXO1 expression [70,115]. This evidence concerns the gene MEG3 and hepatocellular carcinoma.